Business Context and Reporting Period
This summary covers the Form 10-Q filed by Anthem, Inc. (now Elevance Health) for the quarterly period ended September 30, 2003. Anthem is a major health benefits company and an independent licensee of the Blue Cross Blue Shield Association, operating in Indiana, Kentucky, Ohio, Connecticut, New Hampshire, Maine, Colorado, Nevada, and Virginia. As of September 30, 2003, the company served approximately 11.8 million members.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2003 | Nine Months Ended Sep 30, 2003 |
|---|---|---|
| Total Operating Revenue | $4,185.8 million | $12,260.9 million |
| Net Income | $196.5 million | $565.5 million |
| Diluted Earnings Per Share | $1.38 | $3.98 |
| Benefit Expense Ratio | 81.0% | 81.3% |
| Administrative Expense Ratio | 18.7% | 18.5% |
| Cash and Cash Equivalents | $670.1 million (as of Sep 30, 2003) | N/A |
| Total Investments | $6,507.3 million (as of Sep 30, 2003) | N/A |
| Long-Term Debt | $1,662.0 million (as of Sep 30, 2003) | N/A |
| Operating Cash Flow (9 Months) | N/A | $725.7 million |
Material Changes vs. Prior Period
- Revenue Growth: Total operating revenue increased 19% for the quarter and 35% for the nine-month period compared to the prior year. This growth was driven by premium rate increases, membership growth (particularly in National Accounts and Individual segments), and the inclusion of the Trigon Healthcare acquisition in the Southeast segment.
- Profitability: Net income rose 15% for the quarter and 50% for the nine-month period. Income before taxes increased 35% (quarter) and 66% (nine months).
- Expense Trends: Benefit expense increased 19% (quarter) and 32% (nine months), tracking with revenue growth. The benefit expense ratio improved (decreased) by 50 basis points for the quarter and 180 basis points for the nine months, aided by favorable prior year reserve developments and disciplined pricing.
- Membership: Total membership grew 8% year-over-year to 11.8 million. Self-funded membership increased 14%, while fully-insured membership grew 2%.
- Investment Impairments: The company recorded charges of $24.4 million for other-than-temporary impairment of securities during the nine months ended September 30, 2003, compared to $3.1 million in the prior year period.
Guidance, Outlook, and Risks
- Pending Merger: On October 27, 2003, Anthem announced a definitive agreement to merge with WellPoint Health Networks Inc. in a transaction valued at approximately $16.4 billion. Upon completion, expected by mid-2004, Anthem will change its name to WellPoint, Inc. The company has secured a $3.0 billion bridge loan commitment to fund the cash portion of the deal.
- Cost of Care Outlook: Management expects aggregate cost of care trends to range from 10% to 11% through the remainder of 2003, driven by professional and outpatient services costs.
- Segment Outlook: The West segment expects operating margins to decline in the fourth quarter and throughout 2004 due to increased spending on technology systems and the exit from the Nevada Medicaid market.
- Legal Contingencies: The company faces significant litigation, including Multi-District Litigation (MDL) in Miami regarding provider reimbursement practices and RICO violations. A major wrongful death case in Ohio (Dardinger) was resolved in March 2003 with a payment of the remitted judgment, resulting in a release of $24.5 million in reserves.
- Regulatory Risks: The company is subject to ongoing federal reviews of its Medicare fiscal intermediary operations and the Federal Employee Program (FEP). Additionally, the proposed acquisition of Blue Cross and Blue Shield of Kansas was terminated following a Supreme Court ruling in August 2003.
Investor Verification Checklist
- Merger Approval: Verify the status of regulatory and shareholder approvals required for the WellPoint merger, which is critical for the company's future strategic direction.
- Reserve Adequacy: Review the actuarial assumptions regarding unpaid claims liabilities, as a 1% variance in estimates could impact net income by approximately $11.9 million per quarter.
- Investment Portfolio: Assess the impact of the $24.4 million impairment charge and the potential for further impairments given market volatility.
- Legal Exposure: Monitor the outcomes of the MDL provider track cases and the Indiana Supreme Court appeal regarding the Dr. William Lewis class action.
- Debt Capacity: Confirm the company's ability to refinance the $3.0 billion bridge loan with permanent debt financing as planned for mid-2004.